Olufunmilayo Olopade to Tumor Cells, Cultured
This is a "connection" page, showing publications Olufunmilayo Olopade has written about Tumor Cells, Cultured.
Connection Strength
0.390
-
Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers. Cancer Res. 2002 Mar 01; 62(5):1481-8.
Score: 0.046
-
Scaffold-associated regions in the human type I interferon gene cluster on the short arm of chromosome 9. Genomics. 1998 Jan 15; 47(2):217-29.
Score: 0.035
-
Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases. Cancer J Sci Am. 1997 Jul-Aug; 3(4):230-7.
Score: 0.033
-
The 9p21 region in bladder cancer cell lines: large homozygous deletion inactivate the CDKN2, CDKN2B and MTAP genes. Urol Res. 1996; 24(4):239-44.
Score: 0.030
-
Construction of a 2.8-megabase yeast artificial chromosome contig and cloning of the human methylthioadenosine phosphorylase gene from the tumor suppressor region on 9p21. Proc Natl Acad Sci U S A. 1995 Jul 03; 92(14):6489-93.
Score: 0.029
-
Detection of CDKN2 deletions in tumor cell lines and primary glioma by interphase fluorescence in situ hybridization. Cancer Res. 1995 Mar 01; 55(5):984-8.
Score: 0.028
-
Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer. Cancer Res. 1994 Apr 15; 54(8):2060-3.
Score: 0.027
-
Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers. Cancer Res. 1993 May 15; 53(10 Suppl):2410-5.
Score: 0.025
-
Mapping of the shortest region of overlap of deletions of the short arm of chromosome 9 associated with human neoplasia. Genomics. 1992 Oct; 14(2):437-43.
Score: 0.024
-
Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. Cancer Res. 1992 May 01; 52(9):2523-9.
Score: 0.023
-
A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies. PLoS Med. 2006 Dec; 3(12):e486.
Score: 0.016
-
Identification of a 1.2 Kb cDNA fragment from a region on 9p21 commonly deleted in multiple tumor types. Cancer Genet Cytogenet. 2001 Sep; 129(2):93-101.
Score: 0.011
-
Expression of methylthioadenosine phosphorylase cDNA in p16-, MTAP- malignant cells: restoration of methylthioadenosine phosphorylase-dependent salvage pathways and alterations of sensitivity to inhibitors of purine de novo synthesis. Mol Pharmacol. 1997 Nov; 52(5):903-11.
Score: 0.009
-
Detection of 9p deletions in leukemia cell lines by interphase fluorescence in situ hybridization with YAC-derived probes. Cancer Genet Cytogenet. 1995 Aug; 83(1):46-55.
Score: 0.007
-
Increased p16 levels correlate with pRb alterations in human urothelial cells. Cancer Res. 1995 Feb 01; 55(3):493-7.
Score: 0.007
-
Mapping a putative tumor suppressor gene on chromosome 9 bands p21-p22 with microdissection probes. Genomics. 1994 Nov 15; 24(2):211-7.
Score: 0.007
-
Breakpoint junctions of chromosome 9p deletions in two human glioma cell lines. Mol Cell Biol. 1994 Nov; 14(11):7604-10.
Score: 0.007
-
p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res. 1994 Nov 01; 54(21):5547-51.
Score: 0.007
-
Analysis of tumor suppressor gene on human chromosome 9 in mouse x human somatic cell hybrids. Somat Cell Mol Genet. 1994 Sep; 20(5):391-400.
Score: 0.007
-
Distinct deletions of chromosome 9p associated with melanoma versus glioma, lung cancer, and leukemia. Cancer Res. 1994 Jan 15; 54(2):344-8.
Score: 0.007
-
Methylthioadenosine phosphorylase deficiency in human non-small cell lung cancers. Cancer Res. 1993 Mar 01; 53(5):1098-101.
Score: 0.006